Press release
Creative Diagnostics Announces Bacterial DNA Residue Assay Kits (qPCR) for Biological Research
Creative Diagnostics has announced the launch of its new Bacterial DNA Residue Assay Kits (qPCR) for researchers.Creative Diagnostics, a reagent supplier and developer focused on biologics quality control, has announced the launch of its new Bacterial DNA Residue Assay Kits [https://qbd.creative-diagnostics.com/products/bacterial-dna-residue-assay-kits-qpcr-2792.html] (qPCR) for researchers to detect and quantify trace amounts of bacterial DNA contamination in a wide range of biopharmaceutical products, ensuring the highest standards of safety and quality.
Bacterial DNA residue assay kits (qPCR) are essential for maintaining the highest levels of product integrity and compliance in the biopharmaceutical industry. As an expert in bioprocess impurity analysis, Creative Diagnostics offers a range of Bacterial DNA Residue (qPCR) assay kits for the detection of trace levels of bacterial DNA contamination in biopharmaceutical products. By effectively monitoring for bacterial DNA contamination, these assay kits prevent potential adverse effects and ensure that the final product is safe for human use.
These kits use advanced quantitative PCR (qPCR) technology with high sensitivity and specificity to reliably identify and quantify bacterial DNA residues. This is essential to ensure the safety and efficacy of biologics, vaccines and other pharmaceuticals. In addition, each kit comes with pre-optimized reagents and comprehensive instructions for seamless integration into existing laboratory protocols. The rapid and accurate results provided by these kits help manufacturers meet stringent regulatory standards and maintain strict quality control throughout the manufacturing process.
For example, the E. coli DNA Residue Assay Kit (Cat. No. DDNA-021) uses PCR fluorescent probe technology to quantitatively detect residual E. coli DNA in samples. This kit provides rapid, highly specific and reliable detection with a minimum detection limit of fg levels. It contains a quantitative E. coli DNA reference standard and is used in conjunction with Creative Diagnostics Host Cell DNA Prep Kit to accurately determine the amount of residual E. coli DNA in biological samples.
The routine testing method for mycobacteria, the culture method, is time-consuming and does not meet the testing requirements of short-life biological products. To address this limitation, the ResDetFast Trademark Mycobacterium DNA Assay Kit (Cat. No. DDNAF-002), a quantitative fluorescence PCR-based assay designed with primers and probes, targets conserved Mycobacterium sequences for rapid and qualitative detection of Mycobacterium DNA in various biological products, including intermediates, semi-finished and finished products. When used in conjunction with Creative Diagnostics Nucleic Acid Extraction or Purification Kit, this kit can detect Mycobacterium DNA at the 10 CFU level in as little as 1.5 hours.
Creative Diagnostics is committed to providing innovative solutions that support the biopharmaceutical industry. By utilizing these advanced kits, biopharmaceutical manufacturers can proactively monitor and control bacterial contamination, safeguarding the integrity of their products and protecting public health. For more information on Bacterial DNA Residue Assay Kits (qPCR) or project-specific Host Cell DNA Assay Kit development services, please visit https://qbd.creative-diagnostics.com/products/bacterial-dna-residue-assay-kits-qpcr-2792.html.
About Creative Diagnostics
Creative Diagnostics is a global leader in the development and manufacturing of innovative tools and reagents for bioprocess impurity analysis. The company offers a comprehensive portfolio of solutions to support researchers in the quality control of biologics and provides biopharmaceutical quality, purity and safety assays, analytical methods and applications for the biotechnology and biopharmaceutical industries.
Media Contact
Company Name: Creative Diagnostics
Contact Person: Thomas Schmitt
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=creative-diagnostics-announces-bacterial-dna-residue-assay-kits-qpcr-for-biological-research]
State: New York
Country: United States
Website: https://qbd.creative-diagnostics.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Creative Diagnostics Announces Bacterial DNA Residue Assay Kits (qPCR) for Biological Research here
News-ID: 3755086 • Views: …
More Releases from ABNewswire
Active Implantable Medical Devices Market Is Expected to Reach USD 44,906.36 mil …
The leading companies operating in the active implantable medical devices market include Medtronic, Johnson and Johnson Services, Inc., Abbott, Boston Scientific Corporation, LivaNova PLC., Axonics, Inc., Aleva Neurotherapeutics, Sonova Holding AG, Bioventus Inc., CARMAT, Jarvik Heart Inc., BIOTRONIK SE & Co. KG, MicroTransponder Inc., MED-EL Medical Electronics, NeuroPace, Inc., NEVRO CORP., Shree Pacetronix, Cochlear Ltd., Berlin Heart, Blackrock Neurotech, and others.
DelveInsight's "Active Implantable Medical Devices Market Insights, Competitive Landscape, and…
Global Heparin Market Poised to Reach USD 18.19 Billion by 2032, Driven by Risin …
Major players shaping the global heparin market include Pfizer Inc., Dr. Reddy's Laboratories Ltd., Gland Pharma Limited, Sanofi, B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Novartis AG, Baxter, Leo Pharma A/S, and Cardinal Health. Continuous investments in R&D, formulation improvements, mergers, and global distribution partnerships remain vital elements of their growth strategy.
DelveInsight's "Heparin Market Insights, Competitive Landscape, and Market Forecast - 2032" report delivers a comprehensive analysis of…
Global Phage Therapy Pipeline Accelerates as 20+ Biotech Companies Advance Next- …
Key phage therapy companies such as Locus Biosciences, Armata Pharmaceuticals, BiomX, SNIPR Biome, Phagelux, PHAXIAM Therapeutics, Phico Therapeutics, Technophage, and others.
DelveInsight's 'Phage Therapies Competitive Landscape 2025' report provides comprehensive global coverage of pipeline phage therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the phage therapies pipeline domain.
The phage therapy market is witnessing robust growth driven by…
Systemic Juvenile Idiopathic Arthritis Market Analysis 2034 - Competitive Landsc …
Systemic Juvenile Idiopathic Arthritis Companies are Chugai Pharmaceutical, AstraZeneca, Pfizer, Incyte Corporation Novartis, Roche, Genentech, AbbVie, Pfizer, Eli Lilly and Company, Bristol Myers Squibb, Johnson & Johnson, Merck & Co., UCB, Sanofi, and others.
DelveInsight's "Systemic Juvenile Idiopathic Arthritis Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Systemic Juvenile Idiopathic Arthritis, historical and forecasted epidemiology as well as the Systemic Juvenile Idiopathic Arthritis market trends in the…
More Releases for DNA
High-Quality Plasmid DNA Fuels Growth in Global DNA Plasmid Manufacturing Market
🌍 Market Overview
The DNA Plasmid Manufacturing Market is experiencing robust growth as advancements in cell & gene therapy, DNA vaccines, and genetic engineering continue to expand globally. Plasmid DNA plays a critical role as a raw material in the development of advanced therapies, fueling demand across biopharmaceutical research and production.
Key factors driving the market include:
Increasing adoption of gene and cell therapies
Rising prevalence of chronic and rare genetic disorders
Expansion of DNA-based…
DNA Synthesis Market Increasing Demand for Synthetic Genes and DNA Sequences
As demonstrated by Precision Business Insights (PBI), the latest report, the global DNA synthesis market was valued at USD 3,702.0 million in 2023 and is expected to reach USD 10,289.5 million by 2029, growing at a CAGR of 18.6% during the forecast period 2024-2030. The key drivers for the growth of the global DNA synthesis market include increasing demand for synthetic genes and DNA sequences, growing applications in the agriculture…
Wealth DNA Code Review Legit Price? (Wealth Manifestation DNA Code Audio Frequen …
Wealth DNA Code Wealth DNA Code is a digital program with seven minutes of soundtracks that manifest and listen to daily to activate the "Wealth DNA," which is part of your DNA to help you attract wealth by making money a part of your mentality and making your dreams to come true.
https://bit.ly/Visit-The-Official-Website-Here-To-Order-Wealth-DNA-Code
Making money, creating assets as well as increasing wealth are the primary objectives that every human being has to…
DNA Paternity Testing Market Size [2022-2029] -DNA Diagnostics Center, EasyDNA, …
A recent market research report added to repository of MR Accuracy Reports is an in-depth analysis of global DNA Paternity Testing. On the basis of historic growth analysis and current scenario of DNA Paternity Testing place, the report intends to offer actionable insights on global market growth projections. Authenticated data presented in report is based on findings of extensive primary and secondary research. Insights drawn from data serve as excellent…
DNA Paternity Testing Market Trends 2020 | Growth by Top Companies: DNA Diagnost …
The report begins with the overview of the DNA Paternity Testing Market and offers throughout development. It presents a comprehensive analysis of all the regional and major player segments that gives closer insights upon present market conditions and future market opportunities along with drivers, trending segments, consumer behaviour, pricing factors and market performance and estimation. The forecast market information, SWOT analysis, DNA Paternity Testing market scenario, and feasibility study are…
DNA Paternity Testing Market Rapidly Growing in Healthcare, Competitor Analysis …
The exclusive research report on the Global DNA Paternity Testing Market 2020 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market. Global DNA Paternity Testing Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe.
Overview of Global DNA Paternity Testing Market:
This report studies the Global DNA Paternity Testing…
